From Lebanon to Texas, award-winning cancer doctor charts new course for leukemia research
Dr. Hagop Kantarjian, whose life work has transformed research, diagnosis and treatment of leukemia, also expands cancer research networks and collaboration in the Middle East.
Dr. Hagop Kantarjian, chair of the University of Texas MD Anderson Cancer Center leukemia department, is described by his colleagues and peers as “one of the most influential cancer doctors of his generation,” according to a recent profile in the Houston Chronicle.
Kantarjian is this year’s recipient of the prestigious David A. Karnofsky Memorial Award, presented by the American Society of Clinical Oncology to physicians who make outstanding contributions to cancer research and treatment. His leukemia research has transformed patient treatment and care, and improved survival rates for patients with many types of leukemia.
In an exclusive interview with Al-Monitor, Kantarjian discussed his journey from Beirut to MD Anderson in Houston, and why he feels an obligation to give back to Lebanon and the Middle East.
From Beirut to Houston
